Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel
Cancer Med. 2024 Apr;13(7):e7115. doi: 10.1002/cam4.7115. ABSTRACT INTRODUCTION: The objective was to determine the added value of comprehensive molecular profile by whole-exome and RNA sequencing …